This raises a critical problem for understanding the neurobiology of autism and developing effective treatments: how do mutations in general regulators of growth, such as PTEN and other members of the PI3K-Akt-mTOR pathway, lead to the relatively selective behavioural and cognitive symptoms of ASD? This evidence concerns the gene MTOR and autism.